ArticleNature communications2022
A common deletion at BAK1 reduces enhancer activity and confers risk of intracranial germ cell tumors.
Kyuto Sonehara et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this papercites it